Novocure Denmark ApS: Financial statements 2024
CVR: 43071076
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Novocure Denmark ApS (CVR 43071076) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 9,956,127 and a net result of DKK 833,715 compared with DKK 433,261 the year before. That is an increase of 20.3% compared with the year before. Equity in the 2024 report amounted to DKK 1,413,248. The solvency ratio was 40.9%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 9,956,127
- Profit/Loss
- DKK 833,715
- Equity
- DKK 1,413,248
- Total Assets
- DKK 3,456,108
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 10 mio. | 834 t. | 1.4 mio. | 5 |
| 2023 | - | 8.3 mio. | 433 t. | 580 t. | 4 |
| 2022 | - | 1.9 mio. | 106 t. | 146 t. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Novocure Denmark ApS has published its annual report for 2023. Gross profit came to DKK 8,274,042, and the net result was DKK 433,261.
About Novocure Denmark ApS
Novocure Denmark ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Marco Adriano Carrino. The company is owned by Novocure GmbH. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 1,313,877 and a net result of DKK 52,751 compared with DKK 833,715 the year before. Equity in the 2025 report amounted to DKK 1,465,999.